Norges Bank’s Adicet Bio ACET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-26,847
Closed -$413K 1745
2024
Q4
$413K Hold
26,847
﹤0.01% 1806
2024
Q3
$619K Hold
26,847
﹤0.01% 1772
2024
Q2
$520K Hold
26,847
﹤0.01% 1875
2024
Q1
$1.01M Hold
26,847
﹤0.01% 1793
2023
Q4
$812K Hold
26,847
﹤0.01% 1879
2023
Q3
$588K Hold
26,847
﹤0.01% 1915
2023
Q2
$1.04M Buy
+26,847
New +$2.37M ﹤0.01% 1928

Other funds holding ACET

Norges Bank's ACET Position: Q1 2025 in Review

Norges Bank sold out of Adicet Bio (ACET) in Q1 2025, closing a stake of 26,847 shares — an estimated $413K sold.

Norges Bank first reported a position in ACET in Q2 2023 and held it in 7 quarters. The position peaked at $1.04M in Q2 2023. 56 funds tracked by Wall St. Rank hold ACET as of Q1 2025.

  • Norges Bank reported no remaining Adicet Bio position as of Q1 2025 after selling out during the quarter.
  • Norges Bank sold 26,847 Adicet Bio shares in Q1 2025, an estimated $413K.
  • Norges Bank first reported a position in Adicet Bio in Q2 2023 and held it in 7 quarters.
  • Norges Bank's Adicet Bio position peaked at $1.04M in Q2 2023.
  • 56 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2025.

Based on Norges Bank's 13F filing for Q1 2025, filed 13 May 2025.